Welcome to the Saturday edition of Businessweek Daily, featuring the Everybody’s Business podcast. Let us know what you think by emailing the editor. If this newsletter was forwarded to you, click here to sign up. Subscribe to Bloomberg.com for unlimited access to all our coverage. GLP-1s, touted as a miracle drug by many, are slowly disappearing from Americans’ insurance plans. On a new episode of the Everybody’s Business podcast, Bloomberg News workplace reporter Taylor Nicole Rogers explains why companies are saying “no thanks” to one of the hottest classes of pharmaceuticals on the market. Then, hosts Stacey Vanek Smith and Max Chafkin talk debt. It’s hammering the US government, the housing market and many people’s lives. As prices for food, gas, rent and utilities continue their relentless march skyward, more Americans are struggling to make ends meet. At the same time, credit cards and other loans are getting more expensive. Jamie Feldman knows this better than most. She became a social media star a few years ago, when she posted a viral video about struggling with $18,000 of debt. Feldman began documenting her attempts to pay it down, take control of her spending and change her relationship with money. But since she started the podcast Debt Heads with her friend Rachel Webster in 2024, Feldman has learned a lot more about the banking and lending industry — and has a different attitude toward debt. She joins the podcast to discuss what she’s learned along the way. Listen and subscribe on Apple, Spotify, iHeart and the Bloomberg Terminal. More Weekend Reads
Video: How High Speed Traders Made Billions in India
Test Your Knowledge
We’re improving your newsletter experience and we’d love your feedback. If something looks off, help us fine-tune your experience by reporting it here. Follow Us You received this message because you are subscribed to Bloomberg’s Businessweek Daily newsletter. If a friend forwarded you this message, sign up here to get it in your inbox.
|
Saturday, September 26, 2026
Podcast: Dropping GLP-1 coverage
Subscribe to:
Post Comments (Atom)
Make the U.S. Blind-Spot Bet
In today's Masters Series, adapted from the December 4, 2025 issue of the free Altimetry Daily Authority e-letter, Joel Litman explain...
-
Revolutionary Stem Cell & PRP —Start Your Journey Today ...
-
You’ve shown interest in Regenerative Medicine ...


No comments:
Post a Comment